Peripheral nervous system insulin resistance in ob/ob mice

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Grote, Caleb W ^a   Groover, Anna L ^a   Ryals, Janelle M ^a   Geiger, Paige C ^a   Feldman, Eva L ^b   Wright, Douglas E ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Diabetic neuropathy; Neuronal insulin resistance; Neurotrophic support

Indexed keywords

EID: 85005873056     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-1-15     Document Type: Article

References (52)

1. Kim B, Feldman EL: Insulin resistance in the nervous system. Trends Endocrinol Metab 2012,23(3):133-141. 10.1016/j.tem.2011.12.004
2. Singhal A: Near nerve local insulin prevents conduction slowing in experimental diabetes. Brain Res 1997,763(2):209-214. 10.1016/S0006-8993(97)00412-5
3. Brussee V, Cunningham FA, Zochodne DW: Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004,53(7):1824-1830. 10.2337/diabetes.53.7.1824
4. Toth C, Brussee V, Zochodne DW: Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 2006,49(5):1081-1088. 10.1007/s00125-006-0169-8
5. Kim B: Hyperinsulinemia Induces Insulin Resistance in Dorsal Root Ganglion Neurons. Endocrinology 2011,152(10):3638-3647. 10.1210/en.2011-0029
6. Grote CW: Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy. Exp Diabetes Res 2011, 2011: 212571.
7. Singh B: Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 2012,121(2):263-276. 10.1111/j.1471-4159.2012.07681.x
8. Lee KO: Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients. Acta Diabetol 2012,49(2):97-103. 10.1007/s00592-010-0176-6
9. Patel NJ: Glucose and leucine uptake by rat dorsal root ganglia is not insulin sensitive. J Neurol Sci 1994,121(2):159-162. 10.1016/0022-510X(94)90345-X
10. Toth C: Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience 2006,139(2):429-449. 10.1016/j.neuroscience.2005.11.065
11. Guo G: Local insulin and the rapid regrowth of diabetic epidermal axons. Neurobiol Dis 2011,43(2):414-421. 10.1016/j.nbd.2011.04.012
12. Recio-Pinto E, Rechler MM, Ishii DN: Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci 1986,6(5):1211-1219.
13. Fernyhough P: Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res 1993,607(1-2):117-124.
14. Huang TJ: Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003,52(8):2129-2136. 10.2337/diabetes.52.8.2129
15. Chowdhury SK: Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes 2010,59(4):1082-1091. 10.2337/db09-1299
16. McNay EC: Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 2010,93(4):546-553. 10.1016/j.nlm.2010.02.002
17. Craft S: Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial. Arch Neurol 2012,69(1):29-38. 10.1001/archneurol.2011.233
18. Gerozissis K: Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol 2008,585(1):38-49. 10.1016/j.ejphar.2008.01.050
19. Obici S: Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002,8(12):1376-1382. 10.1038/nm1202-798
20. Le Roith D, Zick Y: Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001,24(3):588-597. 10.2337/diacare.24.3.588
21. Cheng Z, Tseng Y, White MF: Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 2010,21(10):589-598. 10.1016/j.tem.2010.06.005
22. Mayer CM, Belsham DD: Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation. Endocrinology 2010,151(1):75-84. 10.1210/en.2009-0838
23. Gavin JR 3rd: Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A 1974,71(1):84-88. 10.1073/pnas.71.1.84
24. Shanik MH: Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008,31(Suppl 2):S262-S268.
25. Garvey WT, Olefsky JM, Marshall S: Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes. J Clin Invest 1985,76(1):22-30. 10.1172/JCI111950
26. Gum RJ: Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 2003,52(1):21-28. 10.2337/diabetes.52.1.21
27. Koren S, Fantus IG: Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2007,21(4):621-640. 10.1016/j.beem.2007.08.004
28. Nieto-Vazquez I: Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 2007,56(2):404-413. 10.2337/db06-0989
29. Kenner KA: Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 1996,271(33):19810-19816. 10.1074/jbc.271.33.19810
30. Paz K: A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997,272(47):29911-29918. 10.1074/jbc.272.47.29911
31. Hirosumi J: A central role for JNK in obesity and insulin resistance. Nature 2002,420(6913):333-336. 10.1038/nature01137
32. Tanti JF, Jager J: Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 2009,9(6):753-762. 10.1016/j.coph.2009.07.004
33. Lee YH: c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 2003,278(5):2896-2902. 10.1074/jbc.M208359200
34. Aguirre V: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000,275(12):9047-9054. 10.1074/jbc.275.12.9047
35. Boura-Halfon S, Zick Y: Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 2009,296(4):E581-E591. 10.1152/ajpendo.90437.2008
36. Drel VR: The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 2006,55(12):3335-3343. 10.2337/db06-0885
37. Kim B: Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxid Redox Signal 2011,14(10):1829-1839. 10.1089/ars.2010.3816
38. Gupte AA, Bomhoff GL, Geiger PC: Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. J Appl Physiol 2008,105(3):839-848. 10.1152/japplphysiol.00148.2008
39. Bitar MS, Al-Mulla F: ROS constitute a convergence nexus in the development of IGF1 resistance and impaired wound healing in a rat model of type 2 diabetes. Dis Model Mech 2012,5(3):375-388. 10.1242/dmm.007872
40. Talbot K: Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012,122(4):1316-1338. 10.1172/JCI59903
41. Kahn CR: Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Exp Diabesity Res 2003,4(3):169-182. 10.1155/EDR.2003.169
42. Schubert M: Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 2003,23(18):7084-7092.
43. Ishii DN: Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Brain Res Rev 1995,20(1):47-67. 10.1016/0165-0173(94)00005-A
44. Dicou E, Attoub S, Gressens P: Neuroprotective effects of leptin in vivo and in vitro. Neuroreport 2001,12(18):3947-3951. 10.1097/00001756-200112210-00019
45. Nguyen MT: JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 2005,280(42):35361-35371. 10.1074/jbc.M504611200
46. Fernyhough P: Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 1999,48(4):881-889. 10.2337/diabetes.48.4.881
47. Langlais P: Global IRS-1 phosphorylation analysis in insulin resistance. Diabetologia 2011,54(11):2878-2889. 10.1007/s00125-011-2271-9
48. Elchebly M: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999,283(5407):1544-1548. 10.1126/science.283.5407.1544
49. Vincent AM: Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011,7(10):573-583. 10.1038/nrneurol.2011.137
50. Murakawa Y: Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev 2002,18(6):473-483. 10.1002/dmrr.326
51. Kim MK: PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo. Eur J Pharmacol 2008,595(1-3):119-125.
52. Chaplan SR: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994,53(1):55-63. 10.1016/0165-0270(94)90144-9